Advisors Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-3,367
| Closed | -$390K | – | 1460 |
|
|
2023
Q3 | $390K | Sell |
3,367
-604
| -15% | -$69.9K | 0.01% | 965 |
|
|
2023
Q2 | $408K | Sell |
3,971
-592
| -13% | -$60.9K | 0.01% | 988 |
|
|
2023
Q1 | $498K | Sell |
4,563
-210
| -4% | -$22.9K | 0.01% | 939 |
|
|
2022
Q4 | $543K | Buy |
4,773
+1,529
| +47% | +$174K | 0.01% | 905 |
|
|
2022
Q3 | $201K | Buy |
3,244
+477
| +17% | +$29.6K | ﹤0.01% | 1144 |
|
|
2022
Q2 | $221K | Buy |
2,767
+813
| +42% | +$64.9K | ﹤0.01% | 1145 |
|
|
2022
Q1 | $206K | Buy |
1,954
+404
| +26% | +$42.6K | ﹤0.01% | 1228 |
|
|
2021
Q4 | $167K | Buy |
1,550
+928
| +149% | +$100K | ﹤0.01% | 1281 |
|
|
2021
Q3 | $68K | Buy |
622
+304
| +96% | +$33.2K | ﹤0.01% | 1337 |
|
|
2021
Q2 | $30K | Sell |
318
-772
| -71% | -$72.8K | ﹤0.01% | 1376 |
|
|
2021
Q1 | $100K | Sell |
1,090
-519
| -32% | -$47.6K | ﹤0.01% | 1335 |
|
|
2020
Q4 | $118K | Sell |
1,609
-875
| -35% | -$64.2K | ﹤0.01% | 1332 |
|
|
2020
Q3 | $193K | Buy |
+2,484
| New | +$193K | ﹤0.01% | 1190 |
|